Muriel Belotti
Overview
Explore the profile of Muriel Belotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Silvestri V, Leslie G, Rebbeck T, Neuhausen S, Hopper J, et al.
J Clin Oncol
. 2022 Jan;
40(14):1529-1541.
PMID: 35077220
Purpose: To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in and for effective cancer risk management. Methods: We...
2.
Caputo S, Golmard L, Leone M, Damiola F, Guillaud-Bataille M, Revillion F, et al.
Am J Hum Genet
. 2021 Oct;
108(10):1907-1923.
PMID: 34597585
Up to 80% of BRCA1 and BRCA2 genetic variants remain of uncertain clinical significance (VUSs). Only variants classified as pathogenic or likely pathogenic can guide breast and ovarian cancer prevention...
3.
Guerra M, Coignard J, Eon-Marchais S, Dondon M, Le Gal D, Beauvallet J, et al.
Breast Cancer Res
. 2021 Aug;
23(1):79.
PMID: 34344426
Background: Diagnostic ionizing radiation is a risk factor for breast cancer (BC). BC risk increases with increased dose to the chest and decreases with increased age at exposure, with possible...
4.
Barnes D, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, et al.
J Natl Cancer Inst
. 2021 Jul;
114(1):109-122.
PMID: 34320204
Background: Recent population-based female breast cancer and prostate cancer polygenic risk scores (PRS) have been developed. We assessed the associations of these PRS with breast and prostate cancer risks for...
5.
Patel V, Busch E, Friebel T, Cronin A, Leslie G, McGuffog L, et al.
Cancer Res
. 2019 Nov;
80(3):624-638.
PMID: 31723001
Pathogenic sequence variants (PSV) in or () are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in were associated with risk of overall prostate cancer...
6.
Lesueur F, Mebirouk N, Jiao Y, Barjhoux L, Belotti M, Laurent M, et al.
Front Oncol
. 2018 Nov;
8:490.
PMID: 30430080
No abstract available.
7.
Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, et al.
J Natl Cancer Inst
. 2018 Oct;
111(4):350-364.
PMID: 30312457
Background: BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2...
8.
Lecarpentier J, Silvestri V, Kuchenbaecker K, Barrowdale D, Dennis J, McGuffog L, et al.
J Clin Oncol
. 2017 Apr;
35(20):2240-2250.
PMID: 28448241
Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time...
9.
Vigorito E, Kuchenbaecker K, Beesley J, Adlard J, Agnarsson B, Andrulis I, et al.
PLoS One
. 2016 Jul;
11(7):e0158801.
PMID: 27463617
Population-based genome wide association studies have identified a locus at 9p22.2 associated with ovarian cancer risk, which also modifies ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We conducted...
10.
Silvestri V, Barrowdale D, Mulligan A, Neuhausen S, Fox S, Karlan B, et al.
Breast Cancer Res
. 2016 Feb;
18(1):15.
PMID: 26857456
Background: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers...